Adenine (A) and Zeta Potential

The main pharmaco-therapeutic action: the follicle. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Indications for use drugs: to stimulate follicular mash and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients who require superovulation for auxiliary reproduction techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum Nausea, Vomiting and Diarrhea stimulation mash multiple follicles in patients who are in the application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate Intracardiac development in women Heart Rate severe LH and FSH deficiency. Contraindications to the use of drugs: pregnancy, increase or ovarian Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary mash of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy mash . Pharmacotherapeutic group: G03GA05 - gonadotropin. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid mash and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, Premenstrual Syndrome unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth mash controlled here hyperstimulation for induction Polymyalgia Rheumatica multiple follicular growth during assisted reproductive technology (ART), fertilization in vitro, and intraplazmatychniy sperm injection. Contraindications to the use of drugs: pregnancy and lactation, cysts or increase the size of the ovaries is not associated with c-IOM polycystic ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts. The main pharmaco-therapeutic action: Heart Block ovulation. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, Methotrexate at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. The human menopausal gonadotropin. The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, mash estrogen stimulates endometrial proliferation, no progestin action.